Frontiers in Aging Neuroscience · 2020 · 54 citations · 36 references
MedicineNeurologyNeuroscienceDementiaMolecular NeuroscienceNeuropharmacologyAlzheimer DiseaseDementia PreventionNeurodegeneration MechanismsNeurodegenerative DiseasesNeurodegenerative DisordersNeuropathology Of AgingAmyloid Beta PeptidesNeuroinflammation In Alzheimer DiseaseNeuroinflammation-related EpigeneticsNeuroinflammatory MarkersNeuroinflammatory MechanismsNeuroinflammatory MediatorsNeuroinflammatory SignalingNucleotide-binding Oligomerization Domain-like Receptor Signaling
Alzheimer’s disease (AD) is a growing global threat to healthcare in the aging population. In the US alone, it is estimated that 1 in 9 persons over the age of 65 is living with AD. The pathology is marked by the accumulation of amyloid-beta (Aβ) deposition in the brain, which is further enhanced by the neuroinflammatory process. Nucleotide-binding oligomerization domain-like receptor (NLRP3) and nuclear factor-kB (NF-kB) are the major neuroinflammatory pathways that intensify AD pathogenesis. Histone deacetylase 2 (HDAC2) mediated epigenetic mechanisms play a major role in the genesis and neuropathology of AD. Therefore, therapeutic drugs, which can target Aβ production, NLRP3 activation, and HDAC2 levels, may play a major role in reducing Aβ levels and the prevention of associated neuropathology of AD. In this study, we demonstrate that Withaferin A (WA), an extract from Withania somnifera plant, significantly inhibits the Aβ production and NF-kB associated neuroinflammatory molecules gene expression. Furthermore, we demonstrate that cytokine release inhibitory drug 3 (CRID3), an inhibitor of NLRP3 significantly prevents inflammasome-mediated gene expression in our in vitro AD model system. We have also observed that Mithramycin A (MTM), an HDAC2 inhibitor, significantly upregulated the synaptic plasticity gene expression and downregulated HDAC2 in SH-SY5Y cells overexpressing amyloid precursor protein (SH-APP cells). Therefore, the introduction of these agents targeting amyloid-beta (Aβ) production, NLRP3 mediated neuroinflammation and HDAC2 levels will have a translational significance in the prevention of neuroinflammation and associated neurodegeneration in AD patients.
36
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Michael T. Heneka, Markus P. Kummer, Andrea Stutz et al. · Nature · 2012 · 2.9K citations · Full text
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Annett Halle, Veit Hornung, Gabor C. Petzold et al. · Nature Immunology · 2008 · 2.4K citations · Full text
HDAC2 negatively regulates memory formation and synaptic plasticity
Ji‐Song Guan, Stephen J. Haggarty, Emanuela Giacometti et al. · Nature · 2009 · 1.6K citations · Full text
Recovery of learning and memory is associated with chromatinremodelling
André Fischer, Farahnaz Sananbenesi, Xinyu Wang et al. · Nature · 2007 · 1.2K citations